0.80%| Prev Close: | 180.23 |
|---|---|
| Open: | 181.28 |
| Bid: | 180.88 x 400 |
| Ask: | 181.90 x 100 |
| NAV¹: | 86.70 |
| Net Assets²: | 2.58B |
| YTD Return (Mkt)²: | 16.55% |
| Day's Range: | 179.75 - 182.10 |
|---|---|
| 52wk Range: | 118.29 - 186.98 |
| Volume: | 495,594 |
| Avg Vol (3m): | 585,662 |
| P/E (ttm)²: | 21 |
| Yield (ttm)²: |
¹As of Nov 29, 2012
²As of Mar 30, 2013
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 1929, 1987, and 2013: Three of a Kind?at Minyanville(Fri, May 17)
- Hyperion Therapeutics Added to NASDAQ Biotechnology Index (NBI)GlobeNewswire(Thu, May 16)
- NewLink Genetics to Be Added to NASDAQ Biotechnology IndexMarketwired(Thu, May 16)
- Oil Pulling Back, Gold Retesting Lows: What 8 Key Charts Are SignalingMinyanville(Wed, May 15)
- IBB, AMGN, CELG, ALXN: ETF Inflow Alertat TheStreet(Tue, May 14)
- Synergy Pharmaceuticals Added to NASDAQ Biotechnology IndexGlobeNewswire(Tue, May 14)
- Daily ETF Roundup: Stocks Finish Flat, IBB And DXJ PopETF Database(Mon, May 13)
- Semi-Annual Changes to the NASDAQ Biotechnology IndexGlobeNewswire(Mon, May 13)
- Issuer Spotlight: iSharesETF Database(Mon, May 13)
- Best ETFs In 2013: DBJP, Tesla-Fueled QCLNIndexUniverse.com(Mon, May 13)
- Positive Prognosis for Biotech ETFsETF Trends(Fri, May 10)
- Why I Am A Biotech Permabullat Seeking Alpha(Tue, May 7)
- Investors Clamor for Generic Drug ETFETF Trends(Mon, May 6)
- IBB, AMGN, CELG, ALXN: ETF Inflow Alertat Forbes(Mon, May 6)
- I Would Buy a Generic Drug ETF, If One Existedat Motley Fool(Thu, May 2)
Reports
- ISHARES NASDAQ BIOTECHNOLOGY I (IBB) 12-months forecastPechala's Reports(May 18)
- IBB: Fundamental Valuation and Predictive Rating ReportNew Constructs, LLC(May 17)
- ValuEngine Industry Report for Finance-public TD INV FDValuEngine, Inc.(May 3)